5mn Research · Coming soon

Our first Spotlights are on their way

Spotlights are condensed, independent research on listed Swiss and European biotech companies, each with its own valuation model. While we prepare the first ones, here are the companies we follow.

Investors and companies are welcome to get in touch: to hear when the first Spotlight is out, to suggest a company, or to talk about coverage.

  • 73listed companies
  • 14countries
  • Dailynews in the Daily Brief
Contact usRead the Daily Brief

Companies we follow

Listed biotech across Europe, plus Swiss medtech and life-science companies, grouped by headquarters.

Switzerland20 companies · SIX-listed or Swiss-headquartered · biotech & medtech

  • AC ImmuneCHACIU · NasdaqNeurodegeneration · vaccines & antibodies
  • ADC TherapeuticsCHADCT · NYSEOncology · Zynlonta (ADC)
  • Addex TherapeuticsCHADXN · SIXNeurology · allosteric modulators
  • Basilea PharmaceuticaCHBSLN · SIXAnti-infectives · Cresemba, Zevtera
  • BioVersysCHBIOV · SIXAntibacterials · BV100, alpibectir
  • Cosmo PharmaceuticalsIECMHC · SIXDermatology & GI · clascoterone
  • CRISPR TherapeuticsCHCRSP · NasdaqGene editing · Casgevy
  • IdorsiaCHIDIA · SIXSleep & hypertension · Quviviq, Tryvio
  • Kuros BiosciencesCHKURN · SIXSpinal fusion · MagnetOs bone graft
  • MedactaCHMOVE · SIXOrthopaedics · hip, knee, shoulder & spine
  • MedartisCHMED · SIXBone fixation · hand, foot & facial surgery
  • Molecular PartnersCHMOLN · SIX, NasdaqOncology · radio-DARPins
  • MoonLake ImmunotherapeuticsCHMLTX · NasdaqInflammation · sonelokimab
  • Newron PharmaceuticalsITNWRN · SIXSchizophrenia · evenamide
  • OculisCHOCS · NasdaqOphthalmology · privosegtor
  • PharvarisCHPHVS · NasdaqHereditary angioedema · deucrictibant
  • Santhera PharmaceuticalsCHSANN · SIXDuchenne · Agamree (vamorolone)
  • StraumannCHSTMN · SIXDentistry · implants & clear aligners
  • VERAXA BiotechCHVRXA · NasdaqOncology · T-cell engagers & ADCs
  • Xlife SciencesCHXLS · SIXLife-science project incubator

Benelux7 companies

  • Agomab TherapeuticsBEAGMB · NasdaqFibrosis · ontunisertib
  • argenxNLARGX · Euronext Brussels, NasdaqImmunology · Vyvgart (FcRn)
  • Lakefront Biotherapeuticsformerly GalapagosBELKFT · Euronext, NasdaqImmunology · gamgertamig
  • NewAmsterdam PharmaNLNAMS · NasdaqCardiometabolic · obicetrapib
  • PharmingNLPHARM · Euronext Amsterdam / PHAR · NasdaqRare diseases · Joenja, Ruconest
  • ProQR TherapeuticsNLPRQR · NasdaqRNA editing · Axiomer
  • uniQureNLQURE · NasdaqGene therapy · AMT-130 (Huntington's)

France14 companies

  • Abionyx PharmaFRABNX · Euronext ParisSepsis & critical care · apoA-I platform
  • AbivaxFRABVX · Euronext Paris, NasdaqUlcerative colitis · obefazimod
  • AdociaFRADOC · Euronext ParisDiabetes · BioChaperone formulations
  • CellectisFRALCLS · Euronext Growth / CLLS · NasdaqGene editing · allogeneic CAR-T
  • DBV TechnologiesFRDBV · Euronext Paris / DBVT · NasdaqFood allergy · Viaskin Peanut
  • GenfitFRGNFT · Euronext ParisLiver diseases · ACLF, Iqirvo (Ipsen)
  • Innate PharmaFRIPH · Euronext Paris / IPHA · NasdaqOncology · IPH4502 (ADC), NK cell engagers
  • InventivaFRIVA · Euronext Paris, NasdaqMASH · lanifibranor
  • MedincellFRMEDCL · Euronext ParisLong-acting injectables · Uzedy (Teva)
  • NanobiotixFRNANO · Euronext Paris / NBTX · NasdaqOncology · JNJ-1900 (NBTXR3)
  • OSE ImmunotherapeuticsFROSE · Euronext ParisImmunology & oncology · Tedopi
  • SensorionFRALSEN · Euronext GrowthHearing loss · gene therapy SENS-501
  • TransgeneFRTNG · Euronext ParisCancer vaccines · TG4050
  • ValnevaFRVLA · Euronext Paris / VALN · NasdaqVaccines · Lyme disease (with Pfizer)

Germany5 companies

  • BioNTechDEBNTX · NasdaqOncology & vaccines · mRNA, pumitamig
  • EvotecDEEVT · Frankfurt / EVO · NasdaqDrug discovery & development partner
  • FormyconDEFYB · FrankfurtBiosimilars · aflibercept, ustekinumab
  • Heidelberg PharmaDEHPHA · FrankfurtOncology · ATAC antibody-drug conjugates
  • ImmaticsDEIMTX · NasdaqOncology · TCR-T anzu-cel (IMA203)

Nordics15 companies

  • AlvotechISALVO · Nasdaq Iceland, NasdaqBiosimilars · Simlandi
  • Ascendis PharmaDKASND · NasdaqEndocrinology · TransCon (Yorvipath, Yuviwel)
  • Bavarian NordicDKBAVA · Nasdaq CopenhagenVaccines · mpox, chikungunya
  • BioArcticSEBIOA B · Nasdaq StockholmAlzheimer's · Leqembi (Eisai)
  • BioInventSEBINV · Nasdaq StockholmOncology antibodies · BI-1808, BI-1206
  • CamurusSECAMX · Nasdaq StockholmLong-acting injectables · Buvidal/Brixadi
  • Cinclus PharmaSECINPHA · Nasdaq StockholmReflux disease · linaprazan glurate
  • Egetis TherapeuticsSEEGTX · Nasdaq StockholmRare diseases · Emcitate (tiratricol)
  • Faron PharmaceuticalsFIFARON · First North Finland / FARN · AIMOncology · bexmarilimab
  • GenmabDKGMAB · Nasdaq Copenhagen, NasdaqOncology antibodies · Epkinly
  • GubraDKGUBRA · Nasdaq CopenhagenObesity · peptide drugs (AbbVie)
  • Hansa BiopharmaSEHNSA · Nasdaq StockholmTransplantation · imlifidase
  • SobiSwedish Orphan BiovitrumSESOBI · Nasdaq StockholmRare diseases · haematology, immunology
  • Vicore PharmaSEVICO · Nasdaq Stockholm / VCRE · NasdaqIPF · buloxibutid
  • Zealand PharmaDKZEAL · Nasdaq CopenhagenObesity · petrelintide (with Roche)

UK & Ireland7 companies

  • Autolus TherapeuticsUKAUTL · NasdaqCell therapy · Aucatzyl (obe-cel)
  • Bicycle TherapeuticsUKBCYC · NasdaqOncology · Bicycle drug conjugates
  • Compass PathwaysUKCMPS · NasdaqDepression · COMP360 psilocybin
  • GH ResearchIEGHRS · NasdaqDepression · GH001 (mebufotenin)
  • ImmunocoreUKIMCR · NasdaqOncology · Kimmtrak, TCR bispecifics
  • ProthenaIEPRTA · NasdaqNeurodegeneration · partnered antibodies
  • Silence TherapeuticsUKSLN · NasdaqsiRNA · divesiran, zerlasiran

Southern & Eastern Europe5 companies

  • MolecurePLMOC · WarsawInflammation & fibrosis · OATD-01
  • Oryzon GenomicsESORY · BMEEpigenetics · iadademstat, vafidemstat
  • PharmaMarESPHM · BMEOncology · Zepzelca (lurbinectedin)
  • PhilogenITPHIL · Euronext MilanOncology · Nidlegy (antibody-cytokine)
  • Ryvu TherapeuticsPLRVU · WarsawOncology · romaciclib

A selection of the listed companies we follow, as of October 2026. Country shows where the company is headquartered. Inclusion is not a recommendation, and does not imply any relationship between 5mn and the company.

Scroll to Top